The high failure rates of transvenous defibrillation leads in implantable cardioverter-defibrillators reported by Kleemann et al 1 are quite disturbing. This article raises many issues about lead design, implantation techniques, and follow-up.
train nonelectrophysiologists to implant defibrillators may further compound this problem. 5 Finally, we believe that the study highlights the need for defibrillation threshold testing during follow-up. Basic interrogations failed to identify one third of the defects. Defibrillation threshold testing would allow measurement of shocking impedance in devices from all manufacturers. Additionally, it may provoke postshock oversensing, a sign of insulation failure. Routine defibrillation threshold testing may allow earlier diagnosis of lead failure and may reduce the incidence of inappropriate shocks. 
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